Tomasz Jankowski, Ahmet Sezer, Mariola Kowal-Rosinska, Veronika Müller, Tibor Csoszi, Tünde Nagy, Rodryg Ramlau, Szabolcs Soter, Constantin D. Volovat, Florin Amurariti, Daniela E. Sirbu, Razvan Bobora, Ilgen Mender, Romina Girotti, Marcel Mitsunaga, Oleg Tudos, Matthew Failor, Vlad Vitoc, Sergei Gryaznov, Victor Zaporojan. "A phase 3 study of ateganosine (THIO; 6-thio-2'-deoxyguanosine) sequenced with immune checkpoint inhibitor (ICI) versus standard-of-care chemotherapy in ICI-resistant advanced NSCLC: THIO-104 trial in progress.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps8672